ELAN - ELAN ACTIVE INVESTIGATION: Contact Levi & Korsinsky if you lost money on your Elanco Animal Health Incorporated investment | Benzinga
NEW YORK, July 02, 2024 (GLOBE NEWSWIRE) -- Levi & Korsinsky notifies investors that it has commenced an investigation of Elanco Animal Health Incorporated ("Elanco") (NYSE:ELAN) concerning possible violations of federal securities laws.
Elanco issued a press release on June 27, 2024, "announc[ing] updates to the expected U.S. Food and Drug Administration (FDA) approval timelines for Zenrelia and Credelio Quattro." The press release stated that Zenrelia is expected to receive FDA approval in the third quarter of 2024, leading to a potential commercial launch in the fourth quarter of 2024. ...